Adenovirus-mediated overexpression of sphingomyelin synthases 1 and 2 increases the atherogenic potential in mice
about
Selective reduction in the sphingomyelin content of atherogenic lipoproteins inhibits their retention in murine aortas and the subsequent development of atherosclerosis.Sphingomyelin metabolism at the plasma membrane: implications for bioactive sphingolipids.Lipid abnormalities in alpha/beta2-syntrophin null mice are independent from ABCA1.Sphingomyelin in high-density lipoproteins: structural role and biological function.Sphingomyelin synthase 2 is one of the determinants for plasma and liver sphingomyelin levels in miceSphingomyelin synthases regulate production of diacylglycerol at the Golgi.Molecular biology of atherosclerosis.Plasma Lipidome Analysis by Liquid Chromatography-High Resolution Mass Spectrometry and Ion Mobility of Hypertriglyceridemic Patients on Extended-Release Nicotinic Acid: a Pilot Study.Sphingomyelin synthase overexpression increases cholesterol accumulation and decreases cholesterol secretion in liver cells.Adenovirus-mediated sphingomyelin synthase 2 increases atherosclerotic lesions in ApoE KO mice.Effects of sepsis on the metabolism of sphingomyelin and cholesterol in mice with liver dysfunction.Pharmacological Activation of Peroxisome Proliferator-Activated Receptor {Delta} Increases Sphingomyelin Synthase Activity in THP-1 Macrophage-Derived Foam Cell.Comparative analysis of sphingomyelin synthase 1 gene expression at the transcriptional and translational levels in human tissues.Patients with Concurrent Tuberculosis and Diabetes Have a Pro-Atherogenic Plasma Lipid Profile.Sphingomyelin synthase 2 promotes H2O2-induced endothelial dysfunction by activating the Wnt/β-catenin signaling pathwayDevelopment, Validation, and Application of a Novel Method for Mammalian Sphingomyelin Synthase Activity Measurement
P2860
Q30524346-11AAD1B0-4118-4C04-B0FC-EE3584CC573DQ33798777-1691A6E8-95D0-4321-9D0D-882A77579E69Q35186664-F3096D11-FCF2-4DC2-895D-FAF1FB5AC082Q36820504-F1E3002C-5677-4700-9BEF-EC3A822AC8BCQ37391027-4FD6B4EB-7E7B-4DBC-80FC-8CA7DF9F5779Q37444626-B07CDF93-0FC6-46FA-912A-1332D10582A2Q38125279-9C05630E-6449-43E2-87BC-A0ACFDA748B3Q38656143-4975FE45-1B41-4F47-BE28-1D80224FC75BQ39573995-397F2BB6-158D-4619-BB36-5BDB587321A2Q42202217-3B3D7069-8838-435D-8259-125B8F41B3DDQ47133156-1CA96C1D-29EC-480C-8EDD-90784DCB441EQ51713067-DB0BA422-DC08-4C56-AAFD-A53D37C215A2Q55060455-FF837AD1-0744-4990-B620-DEDCB9E5D3AFQ55416101-81A6D290-0B2D-484B-9278-A411B5A61561Q57073296-40985DBA-3458-43A8-86DB-31E7C8FACB10Q58183400-4B35E702-3872-4ED0-9C9F-7A8F99D31B9C
P2860
Adenovirus-mediated overexpression of sphingomyelin synthases 1 and 2 increases the atherogenic potential in mice
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Adenovirus-mediated overexpres ...... atherogenic potential in mice
@ast
Adenovirus-mediated overexpres ...... atherogenic potential in mice
@en
Adenovirus-mediated overexpres ...... atherogenic potential in mice
@nl
type
label
Adenovirus-mediated overexpres ...... atherogenic potential in mice
@ast
Adenovirus-mediated overexpres ...... atherogenic potential in mice
@en
Adenovirus-mediated overexpres ...... atherogenic potential in mice
@nl
prefLabel
Adenovirus-mediated overexpres ...... atherogenic potential in mice
@ast
Adenovirus-mediated overexpres ...... atherogenic potential in mice
@en
Adenovirus-mediated overexpres ...... atherogenic potential in mice
@nl
P2093
P2860
P921
P1476
Adenovirus-mediated overexpres ...... atherogenic potential in mice
@en
P2093
Jibin Dong
Manping Wu
Xian-Cheng Jiang
Zhiqiang Li
P2860
P304
P356
10.1194/JLR.M600040-JLR200
P407
P577
2006-06-01T00:00:00Z